An evaluation of the real world use and clinical utility of the Cxbladder Monitor assay in the follow-up of patients previously treated for bladder cancer

BACKGROUND: Surveilling recurrent urothelial carcinoma (UC) requires frequent cystoscopy, which is invasive, expensive and time-consuming. An accurate urinary biomarker has the potential to reduce the number of cystoscopies required during post-treatment surveillance. OBJECTIVE: To audit the clinica...

Descripción completa

Detalles Bibliográficos
Autores principales: Koya, Madhusudan, Osborne, Sue, Chemaslé, Christophe, Porten, Sima, Schuckman, Anne, Kennedy-Smith, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7014779/
https://www.ncbi.nlm.nih.gov/pubmed/32046687
http://dx.doi.org/10.1186/s12894-020-0583-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7014779/
https://www.ncbi.nlm.nih.gov/pubmed/32046687
http://dx.doi.org/10.1186/s12894-020-0583-0

Ejemplares similares